
Description
Images
No Images AvailableProduct Information
Product Size | 25 mg |
Form | Solid |
Absorption (estimated) | Wavelength (λmax): 493 ± 3 nm |
Fluorescence (estimated) | Emission Max: 517 ± 4 nm |
Cell Permeability | Cell-permeant |
Detection Method | Fluorescent |
Storage conditions | Room temperature (RT) Protect from moisture (D) Protect from light (L) |
Shipping conditions | Room temperature |
• 2,4,6(1H,3H,5H)-Pyrimidinetrione, 1,3-dibutyl-5-(3-(1,3-dibutyl-1,2,3,4-tetrahydro-6-hydroxy- 2,4-dioxo-5-pyrimidinyl)-2-propenylidene)-
• Increased cell death in osteopontin-deficient cardiac fibroblasts occurs by a caspase-3-independent pathway." Zohar R, Zhu B, Liu P, Sodek J, McCulloch CA. Am J Physiol Heart Circ Physiol 287, H1730-9 (2004)
• Role of YidC in folding of polytopic membrane proteins." Nagamori S, Smirnova IN, Kaback HR. J Cell Biol 165, 53-62 (2004)
• Regulation of eosinophil membrane depolarization during NADPH oxidase activation." Bankers-Fulbright JL, Gleich GJ, Kephart GM, Kita H, O'Grady SM. J Cell Sci 116, 3221-6 (2003)
For Research Use Only. Not for any animal or human therapeutic or diagnostic use No Animal source |
|||||||
Regulatory Compliance |
|||||||
6277 |
DiBAC4(3) [Bis-(1,3-dibutylbarbituric acid) trimethine oxonol] |
||||||
OSHA Hazard |
No Known OSHA Hazards |
||||||
HMIS Classification |
Health: 0 |
Flammability: 0 |
Physical Hazard: 0 |
||||
NFPA Rating |
Health: 0 |
Fire: 0 |
Reactivity: 0 |
||||
TSCA Status |
Not On TSCA Inventory |
||||||
Transportation Information |
|||||||
DOT (US) |
IMDG |
IATA |
|||||
Not Dangerous Good |
Not Dangerous Good |
Not Dangerous Good |